Provided by Tiger Trade Technology Pte. Ltd.

Vor Biopharma Inc.

18.69
+0.63003.49%
Post-market: 18.800.1100+0.59%19:30 EDT
Volume:773.27K
Turnover:14.36M
Market Cap:1.11B
PE:1.62
High:18.99
Open:18.09
Low:18.09
Close:18.06
52wk High:39.49
52wk Low:6.50
Shares:59.16M
Float Shares:37.23M
Volume Ratio:0.77
T/O Rate:2.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):11.53
EPS(LYR):-70.5015
ROE:-125.43%
ROA:-21.37%
PB:-5.52
PE(LYR):-0.27

Loading ...

Wedbush Adjusts Price Target on Vor Biopharma to $27 From $18, Keeps Neutral Rating

MT Newswires Live
·
Aug 11

Vor Biopharma Shares Drop After Q2 Results

MT Newswires Live
·
Aug 11

Vor Biopharma Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Vor Biopharma Posts Wider-than-Expected Q2 Loss on Increased G&A Costs

Reuters
·
Aug 11

Vor Biopharma Q2 EPS $(1.16) Misses $(0.70) Estimate

Benzinga Earnings
·
Aug 11

Earnings Flash (VOR) Vor Biopharma Posts Q2 Net Loss $1.16 a Share, vs. FactSet Est of $0.70 Loss

MT Newswires Live
·
Aug 11

Vor Biopharma Q2 Net Income USD -62.8 Million VS. Ibes Estimate USD -35.7 Million

THOMSON REUTERS
·
Aug 11

Press Release: Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 11

Vor Bio Grants Stock Options for 32,550 Shares, RSUs for 6,900 Shares to New Hires Under Inducement Plan

Reuters
·
Aug 04

RA Capital Healthcare Fund Disposes of 213 Vor Biopharma Shares Worth $4,206.75

Reuters
·
Jul 22

Vor Biopharma Director David Zaccardelli Files Initial Beneficial Ownership Statement

Reuters
·
Jul 10

Vor Biopharma Adds Industry Veteran David Zaccardelli to Board

TIPRANKS
·
Jul 08

Press Release: Vor Bio Appoints David Zaccardelli to Board of Directors

Dow Jones
·
Jul 08

Why Vor Biopharma (VOR) Is Up 27.9% After Broad Russell Index Inclusion And What's Next

Simply Wall St.
·
Jul 06

Vor Bio Grants Inducement Awards to New Hires, Including Options for 71,200 Shares at $18.39

Reuters
·
Jul 03

Vor Bio Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 03

Vor Biopharma shareholders back directors and governance measures

TIPRANKS
·
Jun 13

Vor Biopharma shareholders approved amended 2021 equity incentive plan at annual meeting

Reuters
·
Jun 13

Vor Bio gains boost from telitacicept IgA nephropathy approval

TIPRANKS
·
Jun 09

Vor Bio Partner Drug Earns Regulatory Approval In China For Sjogren's Disease

MT Newswires Live
·
Jun 08